The Anticancer Potential of T Cell Receptor-Engineered T Cells
Author:
Funder
NIH
Damon Runyon Cancer Research Foundation
Fred Hutchinson Cancer Research Center
MPN Research Foundation
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference65 articles.
1. Adoptive cell transfer as personalized immunotherapy for human cancer;Rosenberg;Science,2015
2. Fundamental mechanisms of immune checkpoint blockade therapy;Wei;Cancer Discov.,2018
3. Re-adapting T cells for cancer therapy: from mouse models to clinical trials;Stromnes;Immunol. Rev.,2014
4. Adoptive T cell therapies: a comparison of T cell receptors and chimeric antigen receptors;Harris;Trends Pharmacol. Sci.,2016
5. Isolation and characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-cell receptor for cancer immunotherapy;Yao;J. Immunother.,2016
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V;Biomolecules and Biomedicine;2024-09-06
2. Cancer immunotherapy and its facilitation by nanomedicine;Biomarker Research;2024-08-03
3. Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment;Med;2024-07
4. Engineered T Cell Receptor for Cancer Immunotherapy;Biomolecules & Therapeutics;2024-06-07
5. The potential and promise for clinical application of adoptive T cell therapy in cancer;Journal of Translational Medicine;2024-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3